Concepedia
Statistics
Publications
10
Citations
566
H-Index
Active since
1993
Affiliations
Abbott (United States)(Current)
Abbott Fund
Abbott (United Kingdom)
Michael Coen is an author at Abbott (United States) specializing in drug discovery, pharmacy, and medicinal chemistry.
Publications per year
1993–2014
Novel Inhibitors of Erm Methyltransferases from NMR and Parallel Synthesis
Philip J. Hajduk, Jürgen Dinges, Jeffrey M. Schkeryantz et al. · Journal of Medicinal Chemistry · 1999 · 119 citations · Full text
Life Sciences, Molecular Biology, Antimicrobial Resistance +16
Phenotype in Candida albicans of a disruption of the BGL2 gene encoding a 1,3-β-glucosyltransferase
Aparna V. Sarthy, Thomas McGonigal, Michael Coen et al. · Microbiology · 1997 · 98 citations
Life Sciences, Genetics, Microbiology +17
Discovery and Characterization of Non-ATP Site Inhibitors of the Mitogen Activated Protein (MAP) Kinases
Kenneth M. Comess, Chaohong Sun, Cele Abad‐Zapatero et al. · ACS Chemical Biology · 2010 · 80 citations
Pharmacy, Medicinal Chemistry, Pharmacology +15
An Ultraefficient Affinity-Based High-Throughout Screening Process: Application to Bacterial Cell Wall Biosynthesis Enzyme MurF
Kenneth M. Comess, Mark E. Schurdak, Martin J. Voorbach et al. · SLAS DISCOVERY · 2006 · 73 citations · Full text
Pharmacy, Biochemistry, Medicinal Chemistry +16
Discovery of novel inhibitors of Bcl-xL using multiple high-throughput screening platforms
Jie Qian, Martin J. Voorbach, Jeffrey R. Huth et al. · Analytical Biochemistry · 2004 · 71 citations
Pharmacy, Medicinal Chemistry, Pharmacology +11
1–5 of 10